MARAVAI LIFESCIENCES HOLDINGS INC (MRVI) competitors & alternatives
Health Care · NASDAQ
MARAVAI LIFESCIENCES HOLDINGS INC (MRVI)'s top competitors and alternatives — its most similar public companies — include Pfizer (PFE), ARCTURUS THERAPEUTICS HOLDINGS INC (ARCT), TWIST BIOSCIENCE CORP (TWST), GINKGO BIOWORKS HOLDINGS INC CLASS (DNA), Moderna (MRNA), Bio-Rad Laboratories (BIO), ALPHA TEKNOVA INC (TKNO), Repligen (RGEN), VAXCYTE INC (PCVX), STANDARD BIOTOOLS INC. (LAB), EMERGENT BIOSOLUTIONS INC (EBS) and Revvity (RVTY). These are MARAVAI LIFESCIENCES HOLDINGS INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top MRVI competitors & alternatives
-
PfizerPFEHealth Care
Global biopharmaceutical company discovering, developing, and manufacturing prescription medicines and vaccines across oncology, immunology, cardiovascular,…
$24.82 (as of 2026-07-22) · market cap $142.0B
-
ARCTURUS THERAPEUTICS HOLDINGS INCARCTHealth Care
Arcturus Therapeutics develops self-amplifying mRNA therapeutics and vaccines, with the first approved sa-mRNA COVID vaccine (KOSTAIVE) generating revenue…
$5.93 (as of 2026-07-22) · market cap $168M
-
TWIST BIOSCIENCE CORPTWSTHealth Care
Twist Bioscience is a synthetic DNA synthesis platform company that enables the design and production of custom DNA molecules for drug development,…
$94.21 (as of 2026-07-22) · market cap $5.8B
-
GINKGO BIOWORKS HOLDINGS INC CLASSDNAHealth Care
Ginkgo Bioworks engineers biology at scale through lab automation, AI-driven R&D services, and biosecurity infrastructure to help customers develop new…
$7.83 (as of 2026-07-22) · market cap $511M
-
ModernaMRNAHealth Care
Moderna is an unprofitable mRNA vaccine and therapeutic company pivoting from peak COVID revenues with a diversified pipeline facing intense competition and…
$58.07 (as of 2026-07-22) · market cap $22.9B
-
Bio-Rad LaboratoriesBIOHealth Care
A multinational life science and clinical diagnostics company providing research tools, diagnostic test systems, and consumables to laboratories and…
$305.96 (as of 2026-07-22) · market cap $8.2B
-
ALPHA TEKNOVA INCTKNOHealth Care
Alpha Teknova is a specialized manufacturer of essential reagents and custom chemical solutions that accelerate the development and production of…
$5.24 (as of 2026-07-22) · market cap $281M
-
RepligenRGENHealth Care
Repligen provides critical, high-efficiency bioprocessing technologies and systems that enable biopharmaceutical companies to manufacture life-saving…
$140.09 (as of 2026-07-22) · market cap $7.9B
-
VAXCYTE INCPCVXHealth Care
Vaxcyte engineers next-generation bacterial vaccines using cell-free protein synthesis to create broader-spectrum, more immunogenic alternatives to existing…
$56.00 (as of 2026-07-22) · market cap $8.1B
-
STANDARD BIOTOOLS INC.LABHealth Care
Standard BioTools provides advanced life science analytical platforms and high-parameter imaging technologies to power discovery in single-cell and spatial…
$0.82 (as of 2026-07-22) · market cap $346M
-
EMERGENT BIOSOLUTIONS INCEBSHealth Care
Emergent BioSolutions is a specialized biopharmaceutical firm that provides critical medical countermeasures and manufacturing services to protect against…
$7.58 (as of 2026-07-22) · market cap $393M
-
RevvityRVTYHealth Care
Revvity is a leading health science technology company providing integrated workflows and reagents spanning drug discovery, development, and diagnostic…
$110.54 (as of 2026-07-22) · market cap $12.3B
Not quite? Describe exactly what you want →
Peers are MARAVAI LIFESCIENCES HOLDINGS INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: MARAVAI LIFESCIENCES HOLDINGS INC (MRVI).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.